Early B cell factor 1 (EBF1) is a transcriptional factor with a variety of roles in cell differentiation and metabolism. However, the functional roles of EBF1 in tumorigenesis remain elusive. Here, we demonstrate that EBF1 is highly expressed in triple-negative breast cancer (TNBC). Furthermore, EBF1 has a pivotal role in the tumorigenicity and progression of TNBC. Moreover, we found that depletion of EBF1 induces extensive cell mitophagy and inhibits tumor growth. Genome-wide mapping of the EBF1 transcriptional regulatory network revealed that EBF1 drives TNBC tumorigenicity by assembling a transcriptional complex with HIF1α that fine-tunes the expression of HIF1α targets via suppression of p300 activity. EBF1 therefore holds HIF1α activity in check to avert extensive mitophagy-induced cell death. Our findings reveal a key function for EBF1 as a master regulator of mitochondria homeostasis in TNBC and indicate that targeting this pathway may offer alternative treatment strategies for this aggressive subtype of breast cancer.
|Journal||Proceedings of the National Academy of Sciences of the United States of America|
|State||Published - Jul 12 2022|
Bibliographical noteFunding Information:
ACKNOWLEDGMENTS. We thank Drs. Cathy Anthony and Binhua Peter Zhou for critical reading and editing of this manuscript and Donna Gil-breath for assistance with graphics. This work was supported by grants from American Cancer Society Research Scholar Award (RSG13187) and
Copyright © 2022 the Author(s).
ASJC Scopus subject areas